Sandbox Reserved 1713: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
<scene name='90/904318/Alk-alkal_binding_surface/2'>ALK-ALKAL binding surface</scene> | <scene name='90/904318/Alk-alkal_binding_surface/2'>ALK-ALKAL binding surface</scene> | ||
<scene name='90/904318/Glycinerichdomain/1'>structure of the glycine-rich domain</scene> | <scene name='90/904318/Glycinerichdomain/1'>structure of the glycine-rich domain</scene> | ||
<scene name='90/904318/Alkalbindingsurfacewmembrane/1'>Binding surface of ALKAL with the membrane</scene> | |||
<scene name='90/904318/Alkal1membraneinteraction/2'>ALKAL's residues that interact with membrane</scene> | <scene name='90/904318/Alkal1membraneinteraction/2'>ALKAL's residues that interact with membrane</scene> | ||
== Disease == | == Disease == | ||
Revision as of 18:58, 27 March 2022
| This Sandbox is Reserved from February 28 through September 1, 2022 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1700 through Sandbox Reserved 1729. |
To get started:
More help: Help:Editing |
Anaplastic Lymphoma Kinase
| ||||||||||||

